Reviewing ATH cash flow report, they have $12.6mill cash in the kitty, which by the report will last a further 2.2 quarters going off current estimates.
Given this, it will cover the last 2 quarters of the trials and some, which by than we will have further data reports, and completion of the trials with results of these trials, which was also stated within the recent webinar, opening us right up to big pharm and others given good reports and FDA orphan drug approval.
ASX had its worst day of losses in 4yrs today, wiping $100b off super accounts.
Given the above, does ATH need to consolidate despite holders likely selling at a loss and current cash flow to cover the remainder of the trials ?...I'm in 2 minds.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Reviewing ATH cash flow report, they have $12.6mill cash in the...
-
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $5.491K | 1.520M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126437200 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.003 |
56 | 89498098 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126437200 | 27 |
0.005 | 29143782 | 28 |
0.006 | 12098927 | 17 |
0.007 | 47601651 | 22 |
0.008 | 22833132 | 23 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online